AnaptysBio Inc (ANAB) USD0.001

Sell:$57.32Buy:$57.41Price decreased$7.59 (11.68%)

NASDAQ:Price decreased2.15%
Market closed |
Prices delayed by at least 15 minutes
Sell:$57.32
Buy:$57.41
Change:Price decreased$7.59 (11.68%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$57.32
Buy:$57.41
Change:Price decreased$7.59 (11.68%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$65.16
Previous close$64.99
Market cap$1.87bn
P/E ratio-99999.99
Volume385,932
Dividend yield0.00%
EMS-

Company information

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. The Company’s lead program, Rosnilimab, is a depleter ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue28.75m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.